180 related articles for article (PubMed ID: 38091662)
1. Prognostic prediction value of the clinical-radiomics tumour-stroma ratio in locally advanced rectal cancer.
Cai C; Hu T; Rong Z; Gong J; Tong T
Eur J Radiol; 2024 Jan; 170():111254. PubMed ID: 38091662
[TBL] [Abstract][Full Text] [Related]
2. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
3. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
[TBL] [Abstract][Full Text] [Related]
4. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
5. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Fang Z; Pu H; Chen XL; Yuan Y; Zhang F; Li H
Abdom Radiol (NY); 2023 Jul; 48(7):2270-2283. PubMed ID: 37085730
[TBL] [Abstract][Full Text] [Related]
6. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
[TBL] [Abstract][Full Text] [Related]
7. Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort.
Boldrini L; Lenkowicz J; Orlandini LC; Yin G; Cusumano D; Chiloiro G; Dinapoli N; Peng Q; Casà C; Gambacorta MA; Valentini V; Lang J
Radiat Oncol; 2022 Apr; 17(1):78. PubMed ID: 35428267
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.
Shahzadi I; Zwanenburg A; Lattermann A; Linge A; Baldus C; Peeken JC; Combs SE; Diefenhardt M; Rödel C; Kirste S; Grosu AL; Baumann M; Krause M; Troost EGC; Löck S
Sci Rep; 2022 Jun; 12(1):10192. PubMed ID: 35715462
[TBL] [Abstract][Full Text] [Related]
9. MRI-based radiomics to predict response in locally advanced rectal cancer: comparison of manual and automatic segmentation on external validation in a multicentre study.
Defeudis A; Mazzetti S; Panic J; Micilotta M; Vassallo L; Giannetto G; Gatti M; Faletti R; Cirillo S; Regge D; Giannini V
Eur Radiol Exp; 2022 May; 6(1):19. PubMed ID: 35501512
[TBL] [Abstract][Full Text] [Related]
10. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment MRI-Based Radiomics for Prediction of Rectal Cancer Outcome: A Discovery and Validation Study.
Huang H; Han L; Guo J; Zhang Y; Lin S; Chen S; Lin X; Cheng C; Guo Z; Qiu Y
Acad Radiol; 2024 May; 31(5):1878-1888. PubMed ID: 37996362
[TBL] [Abstract][Full Text] [Related]
12. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
13. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer.
Tian W; Yang Y; Qin Q; Zhang L; Wang Z; Su L; Zeng L; Chen H; Hu L; Hong J; Huang Y; Zhang Q; Zhao H
Cancer Sci; 2023 Feb; 114(2):619-629. PubMed ID: 36221784
[TBL] [Abstract][Full Text] [Related]
14. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract][Full Text] [Related]
16. Radiomics based on T2-weighted and diffusion-weighted MR imaging for preoperative prediction of tumor deposits in rectal cancer.
Sun Z; Xia F; Lv W; Li J; Zou Y; Wu J
Am J Surg; 2024 Jun; 232():59-67. PubMed ID: 38272767
[TBL] [Abstract][Full Text] [Related]
17. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
[TBL] [Abstract][Full Text] [Related]
18. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
[TBL] [Abstract][Full Text] [Related]
19. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
